Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker MDGL
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Shannon T. Kelley General Counsel | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 1,077 | $400.00 | $430.8K Sale | Form 4 ↗ |
| Nov 6, 2026 | Baker Bros. Advisors LP Director | MDGL Madrigal Pharmaceuticals, Inc. | Buy | 2,000 | $396.61 | $793.2K Buy | Form 4 ↗ |
| Nov 6, 2026 | Baker Bros. Advisors LP Director | MDGL Madrigal Pharmaceuticals, Inc. | Buy | 13,740 | $388.29 | $5.3M Buy | Form 4 ↗ |
| Nov 6, 2026 | Baker Bros. Advisors LP Director | MDGL Madrigal Pharmaceuticals, Inc. | Buy | 60,400 | $383.02 | $23.1M Buy | Form 4 ↗ |
| Nov 4, 2026 | Baker Bros. Advisors LP Director | MDGL Madrigal Pharmaceuticals, Inc. | Buy | 10,080 | $368.11 | $3.7M Buy | Form 4 ↗ |
| Nov 4, 2026 | Baker Bros. Advisors LP Director | MDGL Madrigal Pharmaceuticals, Inc. | Buy | 5,586 | $366.99 | $2.1M Buy | Form 4 ↗ |
| Sep 11, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 120 | $546.38 | $65.6K Sale | Form 4 ↗ |
| Sep 11, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 761 | $544.83 | $414.6K Sale | Form 4 ↗ |
| Sep 11, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 1,539 | $544.02 | $837.2K Sale | Form 4 ↗ |
| Sep 11, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 1,202 | $542.60 | $652.2K Sale | Form 4 ↗ |
| Sep 11, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 368 | $541.64 | $199.3K Sale | Form 4 ↗ |
| Sep 11, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 687 | $540.59 | $371.4K Sale | Form 4 ↗ |
| Sep 11, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 160 | $537.62 | $86.0K Sale | Form 4 ↗ |
| Sep 11, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 218 | $535.94 | $116.8K Sale | Form 4 ↗ |
| Sep 11, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 106 | $534.06 | $56.6K Sale | Form 4 ↗ |
| Sep 11, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 60 | $533.09 | $32.0K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 160 | $542.55 | $86.8K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 362 | $541.65 | $196.1K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 505 | $540.19 | $272.8K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 215 | $539.03 | $115.9K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 520 | $538.30 | $279.9K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 640 | $537.17 | $343.8K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 1,040 | $536.11 | $557.6K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 644 | $535.27 | $344.7K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 396 | $534.20 | $211.5K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 512 | $533.09 | $272.9K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 368 | $531.99 | $195.8K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 522 | $530.23 | $276.8K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 347 | $529.27 | $183.7K Sale | Form 4 ↗ |
| Sep 9, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 131 | $527.88 | $69.2K Sale | Form 4 ↗ |
| Aug 17, 2026 | Shannon T. Kelley General Counsel | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 664 | $514.97 | $341.9K Sale | Form 4 ↗ |
| Jul 20, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 280 | $555.05 | $155.4K Sale | Form 4 ↗ |
| Jul 20, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 1 | $550.72 | $551 Sale | Form 4 ↗ |
| Jul 20, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 153 | $550.01 | $84.2K Sale | Form 4 ↗ |
| Jul 20, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 47 | $548.87 | $25.8K Sale | Form 4 ↗ |
| Jul 20, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 680 | $547.70 | $372.4K Sale | Form 4 ↗ |
| Jul 20, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 269 | $547.08 | $147.2K Sale | Form 4 ↗ |
| Jul 20, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 275 | $545.71 | $150.1K Sale | Form 4 ↗ |
| Jul 20, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 545 | $544.71 | $296.9K Sale | Form 4 ↗ |
| Jul 20, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 110 | $543.79 | $59.8K Sale | Form 4 ↗ |
| Jul 20, 2026 | William John Sibold President and CEO, Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 140 | $542.75 | $76.0K Sale | Form 4 ↗ |
| Jun 1, 2026 | David Soergel Chief Medical Officer | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 1,042 | $495.74 | $516.6K Sale | Form 4 ↗ |
| May 22, 2026 | Richard S. Levy Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 80 | $519.98 | $41.6K Sale | Form 4 ↗ |
| May 22, 2026 | Richard S. Levy Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 782 | $518.76 | $405.7K Sale | Form 4 ↗ |
| May 22, 2026 | Richard S. Levy Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 1,497 | $517.59 | $774.8K Sale | Form 4 ↗ |
| May 22, 2026 | Richard S. Levy Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 723 | $516.87 | $373.7K Sale | Form 4 ↗ |
| May 22, 2026 | Richard S. Levy Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 657 | $515.92 | $339.0K Sale | Form 4 ↗ |
| May 22, 2026 | Richard S. Levy Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 343 | $514.67 | $176.5K Sale | Form 4 ↗ |
| May 22, 2026 | Richard S. Levy Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 40 | $512.97 | $20.5K Sale | Form 4 ↗ |
| May 22, 2026 | Richard S. Levy Director | MDGL Madrigal Pharmaceuticals, Inc. | Sale | 439 | $512.50 | $225.0K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances